Please join Foley and Charles River Associates for a round table discussion with Zack Fang, member of the Chinese State Counsel Health Care Reform Expert Advisory Committee, and fellow panelists, to discuss:
- Myths about the Chinese health care system
- Competition and collaboration with local companies
- Opening China’s hospital market
- Price and market access issues faced by multinational pharmaceutical companies in China
Introduction
- Adria Warren, Senior Counsel, Foley & Lardner LLP
Moderator
- Dr. Elizabeth Xiao-Ru Wang, Principal, Charles River Associates
Panelists
- Dr. Jim Ewing, Partner, Foley & Lardner LLP
- Dr. Zack Fang, member of the Chinese State Counsel Health Care Reform Expert Advisory Committee
- Xiaolin Zhou, Partner, Jun He Law Offices
There is no cost to participate in this program; however, pre-registration is required. For additional information, please contact Delia Dai at [email protected].
People
Related Insights
February 4, 2026
Foley Viewpoints
A New Humanized Fc Mouse Model to De-Risk and Scale Antibody Programs, and Enable Innovation
A recent Science Immunology paper reports a humanized Fc receptor mouse model designed to reflect human immune biology relevant to…
February 4, 2026
Manufacturing Industry Advisor
Navigating Battery Validation Risk In The EV Supply Chain
Vehicle electrification has moved battery system supply chains from a background component into the center of the automotive universe, simultaneously shifting the focus of contract disputes and litigation.
February 2, 2026
Foley Viewpoints
DOL Proposes Sweeping New Disclosure Rules for Pharmacy Benefit Managers
Background On January 30, 2026, the Department of Labor’s (DOL) Employee Benefits Security Administration (EBSA) published proposed…